Back to search

National and Kapodistrian University of Athens

Η κλινική σημασία της ανίχνευσης αγγειογενετικών παραγόντων σε ασθενείς με διαφοροποιημένο καρκίνο θυρεοειδούς αδένα

Abstract

dc:description

Aim: Differentiated thyroid cancer (DTC) is the most common malignancy affecting the endocrine system. Thus, improving our understanding of the underlying mechanisms leading to tumorgenensis is of vital importance. Angiogenesis is a key mechanism in the development of several types of cancer. Previous studies have indicated that angiogenesis is a key factor in DTC progression. In the present study, we examined circulating levels of angiogenesis-related factors Angiopoietin-1, Angiopoietin-2, Vascular Endothelial Growth Factor-A (VEGF-A), Galectin-3 (Gal-3), urokinase type plasminogen activator receptor (uPAR) and plasminogen activation inhibitor -1 (PAI-1) were examined in patients with DTC and in control groups.Patients and methods: One hundred and thirty eight patients were enrolled, who were scheduled to undergo total thyroidectomy with a pre-operative diagnosis of DTC or multinodular goiter (MNG). Fifty eight euthyroid healthy individuals were recruited as controls. After definitive histopathological diagnosis, patients were divided into 3 groups: DTC, microcarcinoma and MNG. Prior to surgery blood samples were obtained to evaluate circulating levels of Ang-1, Ang-2, VEGF, uPAR and PAI-1 employing ELISA. In a random subset of 28 patients, six months after surgery, circulating levels of the afore-mentioned factors were measured again.Results: Significant lower levels of Ang-1 were observed in DTC and microcarcinoma patients as compared to healthy controls (37,790 ± 11,270 pg/ml and 37,190 ± 11,380 pg/ml vs 47,720 ± 20,630 pg/ml respectively, p<0.05). A more salient outcome was observed in patients with MNG as compared to controls (37,430 ± 11,370 pg/ml vs 47,720 ± 20,630 pg/ml, p<0.001). Elevated levels of PAI-1 were observed in microcarcinoma patients compared to controls but this difference failed to achieve significance (p=0.062). A significant increase in Ang-1 levels was observed post-operatively in the subset of patients that were reevaluated (41,690 ± 2,570 pg/ml vs 53,680 ± 3,250 pg/ml, p<0.05). No significant differences were observed in the levels of other factors (p<0.05).Conclusion: The results of this study indicate that the presence of benign (in this case MNG) or malignant disease of the thyroid significantly influences circulating levels of Ang-1. Complete removal of the gland leads to normalization of Ang-1 levels, 6 months after surgery. Further studies are needed to fully elucidate the clinical significance of these findings.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Nixon, Alexandros-Mixail
  • Νίξον, Αλέξανδρος-Μιχαήλ

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/50933

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Nixon, Alexandros-Mixail; Νίξον, Αλέξανδρος-Μιχαήλ. Η κλινική σημασία της ανίχνευσης αγγειογενετικών παραγόντων σε ασθενείς με διαφοροποιημένο καρκίνο θυρεοειδούς αδένα. National and Kapodistrian University of Athens, 2022. http://hdl.handle.net/10442/hedi/50933